Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer.

Yerushalmi, Rinat; Raiter, Annat; Nalbandyan, Karen; Hardy, Britta

Yerushalmi, Rinat; Raiter, Annat; Nalbandyan, Karen; Hardy, Britta.

Afiliación

Yerushalmi R; Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel ; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Raiter A; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel ; Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel.
Nalbandyan K; Department of Pathology, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel.
Hardy B; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel ; Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel.

Oncol Lett ; 10(4): 2149-2155, 2015 Oct.

Article en En | MEDLINE | ID: mdl-26622810

Palabras clave

78-kDa glucose-regulated protein; breast cancer; neoadjuvant treatment; predictive marker; prognostic marker

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncol Lett Año: 2015 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google